Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11871-11876

  Wang, Yong Lian ^a   Bai, Yu ^b   Yao, Wen Jian ^a   Guo, Ling ^a   Wang, Zhong Min ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Disease free survival; Esophageal cancer; LncRNA ZEB1 AS1; Overall survival

Indexed keywords

LONG NON-CODING RNA ZEB1-AS1, HUMAN; LONG UNTRANSLATED RNA; TUMOR MARKER;

CANCER GRADING; CARCINOMA, SQUAMOUS CELL; DISEASE COURSE; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, LONG NONCODING; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 85013290766     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Chen W, He Y, Zheng R, Zhang S, Zeng H, Zou X and He J. Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis 2013; 5: 19-26.
3. Enzinger PC and Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
4. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW and van der Gaast A. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
5. Huttenhofer A, Schattner P and Polacek N. Non-coding RNAs: hope or hype? Trends Genet 2005; 21: 289-297.
6. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
7. Mercer TR, Dinger ME and Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10: 155-159.
8. Zhang HM, Yang FQ, Chen SJ, Che J and Zheng JH. Up regulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol 2015; 36: 2947-2955.
9. Lin L, Gu ZT, Chen WH and Cao KJ. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn Pathol 2015; 10: 14.
10. Zhou B, Jing XY, Wu JQ, Xi HF and Lu GJ. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. Int J Clin Exp Pathol 2014; 7: 8893.
11. Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C, Li H, Zhan Q and Zhu Z. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 2015; [Epub ahead of print].
12. Ponting CP, Oliver PL and Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
13. Yan B and Wang Z. Long noncoding RNA: its physiological and pathological roles. DNA Cell Biol 2012; 31 Suppl 1: S34-41.
14. Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans 2012; 40: 902-906.
15. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012; 338: 1435-1439.
16. Prensner JR and Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407.
17. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer 2015; 14: 3.
18. Shi WH, Wu QQ, Li SQ, Yang TX, Liu ZH, Tong YS, Tuo L, Wang S and Cao XF. Up regulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumour Biol 2015; 36: 2501-2507.
19. Li JY, Ma X and Zhang CB. Over expression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 7938-7944.
20. Wang CM, Wu QQ, Li SQ, Chen FJ, Tuo L, Xie HW, Tong YS, Ji L, Zhou GZ, Cao G, Wu M, Lv J, Shi WH and Cao XF. Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Dig Dis Sci 2014; 59: 591-597.